文献速递白血病贫血与红细胞疾病

急性髓系白血病中红系前体细胞丢失导致铁再分布及其临床意义

Loss of erythroblasts in acute myeloid leukemia causes iron redistribution with clinical implications.
PubMed 文献 · Blood Adv · 2021-01-01

该研究在初诊急性髓系白血病(AML)患者及MLL-AF9诱导的AML小鼠模型中探讨铁代谢。AML呈现独特铁谱:高铁蛋白、低转铁蛋白、高转铁蛋白饱和度(TSAT)和高铁调素,且不依赖炎症或输血;红系前体细胞丢失是铁再分布及TSAT升高的原因。全身铁过载小鼠中AML进展延迟,初诊时TSAT升高与总生存期延长独立相关。

要点

  • 初诊AML患者铁谱为高铁蛋白、低转铁蛋白、高TSAT和高铁调素,不依赖炎症或输血。
  • AML诱导的红系前体细胞丢失导致铁再分布和TSAT升高。
  • 初诊时TSAT升高与AML患者总生存期延长独立相关,可能为预后标志物。

核心结论

  • AML是一种具有独特铁代谢特征的疾病,红系前体细胞丢失驱动铁再分布并升高TSAT。
  • 初诊时TSAT升高与AML患者总生存期延长独立相关,提示TSAT可能是有意义的预后标志物。

研究设计与样本

  • 研究初诊AML患者的铁代谢,并使用同基因MLL-AF9诱导的AML小鼠模型探索机制。

主要发现

  • AML患者表现为高铁蛋白、低转铁蛋白、高TSAT和高铁调素,且不依赖炎症或输血。
  • AML中TSAT升高与其他癌种及炎症性贫血中的观察相反。
  • 在MLL-AF9小鼠模型中,AML诱导的红系前体细胞丢失导致铁再分布和TSAT升高。
  • 在全身铁过载小鼠模型中AML进展延迟。
  • 初诊时TSAT升高与AML患者总生存期延长独立相关。

关键数值与推荐

  • AML患者铁谱特征:高铁蛋白、低转铁蛋白、高TSAT、高铁调素。
  • 初诊时TSAT升高与总生存期延长独立相关。

临床怎么用

  • 初诊AML患者应关注铁代谢指标,尤其是TSAT,可能作为预后评估的参考。
  • TSAT升高可能提示较好的预后,但需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute myeloid leukemia (AML) is a heterogeneous disease with poor prognosis and limited treatment strategies. Determining the role of cell-extrinsic regulators of leukemic cells is vital to gain clinical insights into the biology of AML. Iron is a key extrinsic regulator of cancer, but its systemic regulation remains poorly explored in AML. To address this question, we studied iron metabolism in patients with AML at diagnosis and explored the mechanisms involved using the syngeneic MLL-AF9-induced AML mouse model. We found that AML is a disorder with a unique iron profile, not associated with inflammation or transfusion, characterized by high ferritin, low transferrin, high transferrin saturation (TSAT), and high hepcidin. The increased TSAT in particular, contrasts with observations in other cancer types and in anemia of inflammation. Using the MLL-AF9 mouse model of AML, we demonstrated that the AML-induced loss of erythroblasts is responsible for iron redistribution and increased TSAT. We also show that AML progression is delayed in mouse models of systemic iron overload and that elevated TSAT at diagnosis is independently associated with increased overall survival in AML. We suggest that TSAT may be a relevant prognostic marker in AML.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Lopes M, Duarte TL, Teles MJ, et al. Loss of erythroblasts in acute myeloid leukemia causes iron redistribution with clinical implications. Blood Adv. 2021. PMID: 34402883. doi:10.1182/bloodadvances.2021004373

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。